Market Research Report

BTK Inhibitor Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-8674
  • CAT ID : 7
  • Pages : 112
  • Date : Jun 2023
 

The global BTK Inhibitor market was valued at US$ 911.6 million in 2022 and is projected to reach US$ 1825.9 million by 2029, at a CAGR of 10.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of BTK Inhibitor include Pfizer, Aptose Eiosciences, BeiGene, Hanmi Phamaceutical, Eli Lilly, Merck, Ono Phamaceutical, AbbVie and Zhejiang DTRM Biopharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Bruton's tyrosine kinase (abbreviated Btk or BTK), also known as tyrosine-protein kinase BTK, is a tyrosine kinase that is encoded by the BTK gene in humans. BTK plays a crucial role in B cell development. Currently, BTK inhibitors are mainly applied in the treatments of hematological malignancies.
This report aims to provide a comprehensive presentation of the global market for BTK Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BTK Inhibitor. This report contains market size and forecasts of BTK Inhibitor in global, including the following market information:
Global BTK Inhibitor Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global BTK Inhibitor Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five BTK Inhibitor companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the BTK Inhibitor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global BTK Inhibitor Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global BTK Inhibitor Market Segment Percentages, by Type, 2022 (%)
Tablet
Capsule
Global BTK Inhibitor Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global BTK Inhibitor Market Segment Percentages, by Application, 2022 (%)
Chronic Lymphocytic Leukemia (CLL)
Follicular Lymphoma
Mantle Cell Lymphoma
Waldenstrom Macroglobulinemia
Other Selective B Cell Malignancies
Chronic Graft-versus-host Disease
Others
Global BTK Inhibitor Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global BTK Inhibitor Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies BTK Inhibitor revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies BTK Inhibitor revenues share in global market, 2022 (%)
Key companies BTK Inhibitor sales in global market, 2018-2023 (Estimated), (K Units)
Key companies BTK Inhibitor sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Aptose Eiosciences
BeiGene
Hanmi Phamaceutical
Eli Lilly
Merck
Ono Phamaceutical
AbbVie
Zhejiang DTRM Biopharma
AstraZeneca
Biogen
Outline of Major Chapters:
Chapter 1: Introduces the definition of BTK Inhibitor, market overview.
Chapter 2: Global BTK Inhibitor market size in revenue and volume.
Chapter 3: Detailed analysis of BTK Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of BTK Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global BTK Inhibitor capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 BTK Inhibitor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global BTK Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global BTK Inhibitor Overall Market Size
2.1 Global BTK Inhibitor Market Size: 2022 VS 2029
2.2 Global BTK Inhibitor Revenue, Prospects & Forecasts: 2018-2029
2.3 Global BTK Inhibitor Sales: 2018-2029
3 Company Landscape
3.1 Top BTK Inhibitor Players in Global Market
3.2 Top Global BTK Inhibitor Companies Ranked by Revenue
3.3 Global BTK Inhibitor Revenue by Companies
3.4 Global BTK Inhibitor Sales by Companies
3.5 Global BTK Inhibitor Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 BTK Inhibitor Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers BTK Inhibitor Product Type
3.8 Tier 1, Tier 2 and Tier 3 BTK Inhibitor Players in Global Market
3.8.1 List of Global Tier 1 BTK Inhibitor Companies
3.8.2 List of Global Tier 2 and Tier 3 BTK Inhibitor Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global BTK Inhibitor Market Size Markets, 2022 & 2029
4.1.2 Tablet
4.1.3 Capsule
4.2 By Type - Global BTK Inhibitor Revenue & Forecasts
4.2.1 By Type - Global BTK Inhibitor Revenue, 2018-2023
4.2.2 By Type - Global BTK Inhibitor Revenue, 2024-2029
4.2.3 By Type - Global BTK Inhibitor Revenue Market Share, 2018-2029
4.3 By Type - Global BTK Inhibitor Sales & Forecasts
4.3.1 By Type - Global BTK Inhibitor Sales, 2018-2023
4.3.2 By Type - Global BTK Inhibitor Sales, 2024-2029
4.3.3 By Type - Global BTK Inhibitor Sales Market Share, 2018-2029
4.4 By Type - Global BTK Inhibitor Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global BTK Inhibitor Market Size, 2022 & 2029
5.1.2 Chronic Lymphocytic Leukemia (CLL)
5.1.3 Follicular Lymphoma
5.1.4 Mantle Cell Lymphoma
5.1.5 Waldenstrom Macroglobulinemia
5.1.6 Other Selective B Cell Malignancies
5.1.7 Chronic Graft-versus-host Disease
5.1.8 Others
5.2 By Application - Global BTK Inhibitor Revenue & Forecasts
5.2.1 By Application - Global BTK Inhibitor Revenue, 2018-2023
5.2.2 By Application - Global BTK Inhibitor Revenue, 2024-2029
5.2.3 By Application - Global BTK Inhibitor Revenue Market Share, 2018-2029
5.3 By Application - Global BTK Inhibitor Sales & Forecasts
5.3.1 By Application - Global BTK Inhibitor Sales, 2018-2023
5.3.2 By Application - Global BTK Inhibitor Sales, 2024-2029
5.3.3 By Application - Global BTK Inhibitor Sales Market Share, 2018-2029
5.4 By Application - Global BTK Inhibitor Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global BTK Inhibitor Market Size, 2022 & 2029
6.2 By Region - Global BTK Inhibitor Revenue & Forecasts
6.2.1 By Region - Global BTK Inhibitor Revenue, 2018-2023
6.2.2 By Region - Global BTK Inhibitor Revenue, 2024-2029
6.2.3 By Region - Global BTK Inhibitor Revenue Market Share, 2018-2029
6.3 By Region - Global BTK Inhibitor Sales & Forecasts
6.3.1 By Region - Global BTK Inhibitor Sales, 2018-2023
6.3.2 By Region - Global BTK Inhibitor Sales, 2024-2029
6.3.3 By Region - Global BTK Inhibitor Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America BTK Inhibitor Revenue, 2018-2029
6.4.2 By Country - North America BTK Inhibitor Sales, 2018-2029
6.4.3 US BTK Inhibitor Market Size, 2018-2029
6.4.4 Canada BTK Inhibitor Market Size, 2018-2029
6.4.5 Mexico BTK Inhibitor Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe BTK Inhibitor Revenue, 2018-2029
6.5.2 By Country - Europe BTK Inhibitor Sales, 2018-2029
6.5.3 Germany BTK Inhibitor Market Size, 2018-2029
6.5.4 France BTK Inhibitor Market Size, 2018-2029
6.5.5 U.K. BTK Inhibitor Market Size, 2018-2029
6.5.6 Italy BTK Inhibitor Market Size, 2018-2029
6.5.7 Russia BTK Inhibitor Market Size, 2018-2029
6.5.8 Nordic Countries BTK Inhibitor Market Size, 2018-2029
6.5.9 Benelux BTK Inhibitor Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia BTK Inhibitor Revenue, 2018-2029
6.6.2 By Region - Asia BTK Inhibitor Sales, 2018-2029
6.6.3 China BTK Inhibitor Market Size, 2018-2029
6.6.4 Japan BTK Inhibitor Market Size, 2018-2029
6.6.5 South Korea BTK Inhibitor Market Size, 2018-2029
6.6.6 Southeast Asia BTK Inhibitor Market Size, 2018-2029
6.6.7 India BTK Inhibitor Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America BTK Inhibitor Revenue, 2018-2029
6.7.2 By Country - South America BTK Inhibitor Sales, 2018-2029
6.7.3 Brazil BTK Inhibitor Market Size, 2018-2029
6.7.4 Argentina BTK Inhibitor Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa BTK Inhibitor Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa BTK Inhibitor Sales, 2018-2029
6.8.3 Turkey BTK Inhibitor Market Size, 2018-2029
6.8.4 Israel BTK Inhibitor Market Size, 2018-2029
6.8.5 Saudi Arabia BTK Inhibitor Market Size, 2018-2029
6.8.6 UAE BTK Inhibitor Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer BTK Inhibitor Major Product Offerings
7.1.4 Pfizer BTK Inhibitor Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Aptose Eiosciences
7.2.1 Aptose Eiosciences Company Summary
7.2.2 Aptose Eiosciences Business Overview
7.2.3 Aptose Eiosciences BTK Inhibitor Major Product Offerings
7.2.4 Aptose Eiosciences BTK Inhibitor Sales and Revenue in Global (2018-2023)
7.2.5 Aptose Eiosciences Key News & Latest Developments
7.3 BeiGene
7.3.1 BeiGene Company Summary
7.3.2 BeiGene Business Overview
7.3.3 BeiGene BTK Inhibitor Major Product Offerings
7.3.4 BeiGene BTK Inhibitor Sales and Revenue in Global (2018-2023)
7.3.5 BeiGene Key News & Latest Developments
7.4 Hanmi Phamaceutical
7.4.1 Hanmi Phamaceutical Company Summary
7.4.2 Hanmi Phamaceutical Business Overview
7.4.3 Hanmi Phamaceutical BTK Inhibitor Major Product Offerings
7.4.4 Hanmi Phamaceutical BTK Inhibitor Sales and Revenue in Global (2018-2023)
7.4.5 Hanmi Phamaceutical Key News & Latest Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Company Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly BTK Inhibitor Major Product Offerings
7.5.4 Eli Lilly BTK Inhibitor Sales and Revenue in Global (2018-2023)
7.5.5 Eli Lilly Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck BTK Inhibitor Major Product Offerings
7.6.4 Merck BTK Inhibitor Sales and Revenue in Global (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Ono Phamaceutical
7.7.1 Ono Phamaceutical Company Summary
7.7.2 Ono Phamaceutical Business Overview
7.7.3 Ono Phamaceutical BTK Inhibitor Major Product Offerings
7.7.4 Ono Phamaceutical BTK Inhibitor Sales and Revenue in Global (2018-2023)
7.7.5 Ono Phamaceutical Key News & Latest Developments
7.8 AbbVie
7.8.1 AbbVie Company Summary
7.8.2 AbbVie Business Overview
7.8.3 AbbVie BTK Inhibitor Major Product Offerings
7.8.4 AbbVie BTK Inhibitor Sales and Revenue in Global (2018-2023)
7.8.5 AbbVie Key News & Latest Developments
7.9 Zhejiang DTRM Biopharma
7.9.1 Zhejiang DTRM Biopharma Company Summary
7.9.2 Zhejiang DTRM Biopharma Business Overview
7.9.3 Zhejiang DTRM Biopharma BTK Inhibitor Major Product Offerings
7.9.4 Zhejiang DTRM Biopharma BTK Inhibitor Sales and Revenue in Global (2018-2023)
7.9.5 Zhejiang DTRM Biopharma Key News & Latest Developments
7.10 AstraZeneca
7.10.1 AstraZeneca Company Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca BTK Inhibitor Major Product Offerings
7.10.4 AstraZeneca BTK Inhibitor Sales and Revenue in Global (2018-2023)
7.10.5 AstraZeneca Key News & Latest Developments
7.11 Biogen
7.11.1 Biogen Company Summary
7.11.2 Biogen BTK Inhibitor Business Overview
7.11.3 Biogen BTK Inhibitor Major Product Offerings
7.11.4 Biogen BTK Inhibitor Sales and Revenue in Global (2018-2023)
7.11.5 Biogen Key News & Latest Developments
8 Global BTK Inhibitor Production Capacity, Analysis
8.1 Global BTK Inhibitor Production Capacity, 2018-2029
8.2 BTK Inhibitor Production Capacity of Key Manufacturers in Global Market
8.3 Global BTK Inhibitor Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BTK Inhibitor Supply Chain Analysis
10.1 BTK Inhibitor Industry Value Chain
10.2 BTK Inhibitor Upstream Market
10.3 BTK Inhibitor Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 BTK Inhibitor Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe